Raltegravir

• Description:

  A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  444.4164

• Molecular Formula:

  C20H21FN6O5

• Notes:

  Research use only, not for human use.

• Receptor:

  Integrase (S217QPFV) |Integrase (WTPFV)

• CAS Number:

  518048-05-0